Clinical trial
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral…
NCT00401947 · Alexion Pharmaceuticals, Inc., Industry · Terminated
Key facts
| NCT number | NCT00401947 |
|---|---|
| Title | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Multiple Doses of ACH-0137171 in Subjects With Chronic Hepatitis C Infection |
| Lead sponsor | Alexion Pharmaceuticals, Inc., Industry |
| Collaborators | Achillion, a wholly owned subsidiary of Alexion Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HCV Infection |
| Intervention type | Drug |
| Interventions | ACH-0137171 |
| Enrollment | 30 |
| Start date | Nov 30, 2006 |
| Completion | Mar 31, 2007 |
| First posted | Nov 22, 2006 |
| Last update posted | Sep 15, 2022 |
| Countries | Germany, Netherlands, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: